The store will not work correctly when cookies are disabled.
(S)-beta-salicyloylamino-alpha-exo-methylene-gamma-butyrolactone
ID: ALA4084402
Cas Number: 1443448-82-5
PubChem CID: 137647276
Product Number: S646776, Order Now?
Max Phase: Preclinical
Molecular Formula: C12H11NO4
Molecular Weight: 233.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: C=C1C(=O)OC[C@H]1NC(=O)c1ccccc1O
Standard InChI: InChI=1S/C12H11NO4/c1-7-9(6-17-12(7)16)13-11(15)8-4-2-3-5-10(8)14/h2-5,9,14H,1,6H2,(H,13,15)/t9-/m1/s1
Standard InChI Key: SBEBFCLNXGMFOQ-SECBINFHSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
6.7978 -2.8538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7967 -3.6810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5114 -4.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2278 -3.6806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2249 -2.8502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5095 -2.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0833 -2.4415 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0819 -4.0930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3679 -3.6799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0813 -4.9179 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6531 -4.0919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8991 -3.7561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3466 -4.3688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7586 -5.0836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5655 -4.9126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4225 -5.8369 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1779 -5.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
2 8 1 0
8 9 1 0
8 10 2 0
11 9 1 1
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 11 1 0
14 16 2 0
15 17 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 233.22 | Molecular Weight (Monoisotopic): 233.0688 | AlogP: 0.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.63 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.19 | CX Basic pKa: ┄ | CX LogP: 1.83 | CX LogD: 1.76 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.58 | Np Likeness Score: 0.38 |
References
1. Sidthipong K, Ma J, Yu WL, Wang YF, Kobayashi S, Kishino S, Koide N, Yokochi T, Kato K, Okada S, Umezawa K.. (2017) Rational design, synthesis and in vitro evaluation of novel exo-methylene butyrolactone salicyloylamide as NF-κB inhibitor., 27 (3): [PMID:28003138] [10.1016/j.bmcl.2016.12.017] |